| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.05. | Medexus Pharmaceuticals Inc: Medexus's Metoject patent no longer in effect in Canada | 1 | Stockwatch | ||
| 01.05. | Medexus Pharmaceuticals Inc.: Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada | 343 | Newsfile | Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - May 1, 2024) - Following a trial in January 2023, Canada's Federal Court has issued a judgment declining to uphold the Canadian patent for... ► Artikel lesen | |
| 02.04. | Medexus Pharmaceuticals Inc.: Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference | 257 | Newsfile | Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that company management will be participating in... ► Artikel lesen | |
| 26.03. | Medexus Pharmaceuticals Inc: Medexus gets Ixinity supplemental biologics licence OK | 4 | Stockwatch | ||
| 08.02. | Medexus Pharmaceuticals Inc: Medexus loses $500,000 in fiscal Q3 2024 | 1 | Stockwatch | ||
| 08.02. | Medexus Pharmaceuticals Inc.: Medexus Announces Fiscal Q3 2024 Results | 427 | Newsfile | Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 millionManagement to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024Toronto... ► Artikel lesen | |
| 30.01. | Medexus Pharmaceuticals Inc: Medexus to release Q3 2024 results Feb. 7 | 1 | Stockwatch | ||
| 30.01. | Medexus Pharmaceuticals Inc.: Medexus Schedules Third Fiscal Quarter 2024 Conference Call | 261 | Newsfile | Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday,... ► Artikel lesen | |
| 08.01. | Medexus Pharmaceuticals Inc: Medexus nail lacquer accepted for Health Canada review | 1 | Stockwatch | ||
| 08.01. | Medexus Pharmaceuticals Inc.: Health Canada Accepts for Review Medexus's New Drug Submission for Topical Terbinafine | 329 | Newsfile | Topical terbinafine has been widely used in other markets to treat fungal nail infectionsIf and when approved, the product will enter the topical fungicides market that is estimated to be C$88 million... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| TUI | 4.867 |
| NVIDIA | 3.359 |
| GAMESTOP | 2.624 |
| NEL | 2.423 |
| EVOTEC | 2.114 |
| BAYER | 2.056 |
| PLUG POWER | 1.877 |
| BYD | 1.407 |
| VOLKSWAGEN | 950 |
| SUPER MICRO COMPUTER | 913 |
| DEUTSCHE LUFTHANSA | 859 |
| RHEINMETALL | 836 |
| BIONTECH | 806 |
| AIXTRON SE | 788 |
| BASF | 608 |
| DEUTSCHE BANK | 601 |
| DEUTSCHE TELEKOM | 594 |
| ALLIANZ | 593 |
| PALANTIR TECHNOLOGIES | 588 |
| TESLA | 583 |
| THYSSENKRUPP | 583 |
| NOVAVAX | 564 |
| SIEMENS ENERGY | 552 |
| RWE | 551 |
| OMV | 544 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
